Covered recipient · General Payments record
LINDSEY B JOHNSON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,502.10
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $328.17 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CSL Behring | $52.17 | 2 |
| Lilly USA, LLC | $36.73 | 2 |
| UCB, Inc. | $33.83 | 1 |
| Neurelis, Inc. | $24.21 | 1 |
| Amneal Pharmaceuticals LLC | $23.59 | 1 |
| Lundbeck LLC | $23.17 | 1 |
| SK Life Science, Inc. | $23.13 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.37 | 1 |
| Alexion Pharmaceuticals, Inc. | $20.89 | 1 |
| EISAI INC. | $19.43 | 1 |
| PFIZER INC. | $17.56 | 1 |
| Neurocrine BioSciences, Inc. | $17.48 | 1 |
| ABBVIE INC. | $14.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.61 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107411957 | CMS |
| Alexion Pharmaceuticals, Inc. | $20.89 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093975182 | CMS |
| Amneal Pharmaceuticals LLC | $23.59 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139211870 | CMS |
| CSL Behring | $23.09 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134661691 | CMS |
| CSL Behring | $29.08 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134661693 | CMS |
| Eisai Inc. | $19.43 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110812046 | CMS |
| Lilly USA, LLC | $17.45 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135817252 | CMS |
| Lilly USA, LLC | $19.28 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135794172 | CMS |
| Lundbeck LLC | $23.17 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146041418 | CMS |
| Neurelis, Inc. | $24.21 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665677 | CMS |
| Neurocrine Biosciences, Inc. | $17.48 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150992488 | CMS |
| Novartis Pharmaceuticals Corporation | $21.37 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087131026 | CMS |
| PFIZER INC. | $17.56 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130921165 | CMS |
| SK Life Science, Inc. | $23.13 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154145186 | CMS |
| UCB, Inc. | $33.83 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143156373 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.